Keyword

BML-111

Description: BML-111 is a synthetic agonist of the lipoxin A4 receptor studied for anti-inflammatory and tissue-protective effects in experimental medicine.
OpenAlex ID: keywords/bml-111
2010 · Ying Chen, Hua Hao, et al. · Molecular Cancer Therapeutics · 104
2010 · FP Conte, O Menezes‐de‐Lima, et al. · British Journal of Pharmacology · 99
2013 · Regina Sordi, Octávio Menezes-de-Lima, et al. · International Immunopharmacology · 54
2017 · Xia Kong, Sheng-Hua Wu, et al. · Experimental and Therapeutic Medicine · 46
2018 · Hongbin Li, Huijuan Shi, et al. · Archives of Biochemistry and Biophysics · 42
2018 · Yuan Cao, Xiaoyan Zhou, et al. · Prostaglandins & Other Lipid Mediators · 40
2020 · Rafael I. Jaén, María Fernández‐Velasco, et al. · The FASEB Journal · 32
2016 · Dan Yan, Hai-Ling Liu, et al. · International Journal of Molecular Sciences · 31
2020 · Renata M. Martinez, Victor Fattori, et al. · Molecules · 30
Works count: 118
Citation count: 1,970
Year
Topic
Type